Harry Quon, M.D., F.R.C.P.C., MS (CRM)
Assistant Professor of Radiation Oncology
Education
- B.Sc. (Hons) University of Toronto, Immunology, Human Biology 1989
- M.D. University of Toronto 1993
- M.S. (CRM) Albert Einstein College of Medicine (NIH K30-sponsored clinical research training program) 2000-2002
- PGY-1 in Radiation Oncology, North York General Hospital, Toronto, ON, CA 1993-1994
- Resident in Internal Medicine, The Toronto Hospital, Toronto, ON, CA 1994-1995
- Resident in Radiation Oncology, Princess Margaret Hospital, Toronto, ON, CA, Toronto Sunnybrook Regional Cancer Center, Toronto, ON, CA 1994-1998
- Clinical Research Fellowship, Head and Neck and Gastrointestinal Malignancies, Princess Margaret Hospital, Toronto, ON, CA 1998-1999
- Clinical Fellowship, Head and Neck Malignancies, brachytherapy with emphasis on acquiring skills in performing head and neck brachytherapy implants, Beth Israel Medical Center, New York, NY 1999-2000
Board Certification
- Fellow of the Royal College of Physicians and Surgeons of Canada 1998
- American Board of Radiology, Radiation Oncology 1999
Areas of Interest
Publications
Quon, H., Shepherd, F.A., Payne, D.G., Coy, P., Murray, N., Feld, R., Pater, J.,Sadura, A., Zee, B.: The influence of age on the delivery, tolerance and efficacy of thoracis irradiation in the combined modality treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 43:39-45, 1999.
Quon, H., Liu, F.F., Cummings, B.J.: Potential molecular prognostic markers in head and neck squamous cell carcinoma. Head and Neck 23:147-159, 2001.
Patel, N.S., Chiu-Tsao, S.T., Fan, P., Ahunbay, E., Ravi, K., Sherman, W., Quon, H., Pisch, J., Tsao, H.S., Harrison, L.B.: Treatment planning dosimetric parameters for a (90)Y coil source used in intravascular brachytherapy. Cardiovasc Radiat Med 2:83-92, 2001.
Maehara A., Patel N.S., Harrison L.B., Weissman N.J., Bui A.B., Kim H.S., Ajani A.E., Castagna M.T., McMillan T.L., Yang N., Chan R., Pisch J., Quan H., Chiu-Tsao S.T., Waksman R., Mintz G.S.: Dose heterogeneity may not affect the neointimal proliferation after gamma radiation for in-stent restenosis: a volumetric intravascular ultrasound dosimetric study. J Am Coll Cardiol. 39:1937-42., 2002
Patel, N.S., Chiu-Tsao, S.T., Ho, Y., Duckworth, T., Shih, J.A., Tsao, H.S., Quon, H., Harrison, L.B.: High beta and electron dose from 192Ir: implications for “gamma” intravascular brachytherapy. Int J Radiat Oncol Biol Phys 54:972-80, 2002.
Patel, N.S., Fan, P., Chiu-Tsao, S.T., Ravi, K., Sherman, W., Quon, H., Pisch, J., Tsao, H.S., Harrison, L.B.: Ytterbium-169: A promising new radionuclide for intravascular brachytherapy. Cardiovasc Radiat Med 2:173-80, 2001.
Quon, H., Harrison, L.B.: Brachytherapy in the treatment of head and neck cancer. Oncology 16:1379-93, 2002.
Quon, H: Brachytherapy in pediatric oncology. Med Pediatr Oncol 41:5612, 2003
» TOP
© University of Pennsylvania | School of Medicine | University of Pennsylvania Health System